News-Medical.Net on MSN4d
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
ScienceAlert on MSN2d
New Protein Discovery Could Rival Ozempic With Fewer Side EffectsScientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...
People on Ozempic and other GLP-1 agonist drugs commonly report they no longer have constant, incessant thoughts about food. This is how the drugs work.
Interesting Engineering on MSN6d
AI finds natural peptide that matches Ozempic’s weight loss power without side effectsStanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...
Researchers at Stanford Medicine have discovered a naturally occurring molecule that mimics the effects of semaglutide ...
Elisa Caffrey, a microbiology and immunology doctoral candidate at Stanford University, agrees, noting the potential of ...
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...
The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...
AbbVie is paying $350 million to join the obesity race. The outlay, plus up to $1.875 billion in milestones, has landed the ...
A turning point came in the 1980s, when a molecule similar to GLP-1 was discovered in the saliva of the venomous Gila monster (Heloderma suspectum). Scientists realised the molecule latched onto ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback